BCL-X and the apoptotic machinery of lymphoma cells

Leukemia and Lymphoma

Volumn 28, Issue 5-6, 1998, Pages 451-458

  Xerri, Luc ^a,b   Hassoun, Jacques ^a,b   Devilard, Elisabeth ^a,b   Birnbaum, Daniel ^a,b   Birg, Françoise ^a,b  

^a Department of Pathology ^*

^b INSERM   (France)

Author keywords

Apoptosis; BCL 2 family; BCL X; CPP32; FAS; Hodgkin's disease; Non Hodgkin's lymphoma

Indexed keywords

MESSENGER RNA; PROTEIN BCL 2;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; APOPTOSIS; BCL X GENE; CELL DEATH; HUMAN; HUMAN CELL; LYMPHOID TISSUE; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATOR GENE; REPRESSOR GENE; REVIEW;

EID: 0031901001     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809058352     Document Type: Review

References (82)

1. Oltvai, Z. N. and Korsmeyer, S. J. (1994). Checkpoints of dueling dimers foil death wishes. Cell, 79, 189-192.
2. William, G. T. and Smith, C. A. (1993). Molecular regulation of apoptosis: genetic controls on cell death. Cell, 74, 777-779.
3. Korsmeyer, S. J. (1992). Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood, 80, 879-886.
4. Yang, E. and Korsmeyer, S. J. (1996). Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood, 88, 386-401.
5. Oltvai, Z. N., Millman, C. L. and Korsmeyer, S. J. (1993). Bcl2 heterodimerizes m vivo with a conserved homolog, bax, that accelerates programed cell death. Cell, 74, 609-619.
6. Yang, E., Zha, J., Jockei, J., Boise, L. H., Thompson, C. B. and Korsmeyer, S. J. (1995). Bad, a heterodimeric partner for bclxS and bcl-2, displaces bax and promotes cell death. Cell, 80, 285-291.
7. Kiefer, M. C., Brauer, M. J., Powers, V. C., Wu, J. J., Umansky, S. R., Tomei, L. D. and Barr, P. J. (1995). Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature, 374, 736-739.
8. Chittenden, T., Harrington, E. A., O'Connor, R., Flemington, C, Luttz, R. J., Evan, G. I. and Guild, B. C. (1995). Induction of apoptosis by the Bcl-2 homologue Bak. Nature, 374, 733-736.
9. Farrow, S. N., White, J. H. M., Martinou, I., Raven, T., Pun, K. T., Grinham, C. J., Martinou, J. C. and Brown, R. (1995). Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Mmre, 314, 731-733.
10. Kozopas, K. M., Yang, T., Buchan, H. L., Zhou, P. and Craig, R. W. (1993). MCL-1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to Bcl-2. Proceedings of the National Academy of Sciences of the United Slates of America, 90, 3516-3520.
11. Takayama, S., Sato, T., Krajewski, S., Kochel, K., Irie, S., Millan, J. A. and Reed, J. C. (1995). Cloning and functional analysis of BAG-1 : a novel Bcl-2 binding protein with anticell death activity. Cell, 80, 279-284.
12. Sato, T., Hanada, M., Bodrug, S., Irie, S., Iwama, N., Boise, L. H., Thompson, C. B., Golemis, E., Fong, L., Wang, H. G. and Reed, J. C. (1994). Interactions among members of the Bcl-2 protein family analysed with a yeast two-hybrid system. Proceedings of the National Academy of Sciences of the United States of America, 91, 9238-9246.
13. Boise, L. H., Gonzales-Garcia, M., Postema, C. E., Ding, L., Lindten, T., Turka, L. A., Man, X., Numez, G. and Thompson, C. B. (1993). Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74, 597-608.
14. Krajewski, S., Krajewski, M., Shabaik, A., Wang, H. C., Irie, S., Fong, L. and Reed, J. C. (1994). Immunohistochemical analysis of in vivo patterns of bcl-x expression. Cancer Research, 54, 5501-5507.
15. Motoyama, N., Wang, F., Roth, K. A., Sawa, H., Nakayama, K. I., Nakayama, K., Neghishi, I., Senju, S., Zhang, Q., Fujii, S. and Loh, D. Y. (1995). Massive cell death of immature hemopoietic cells and neurons in bcl-x deficient mice. Science, 267, 1506-1509.
16. Minn, A. J., Boise, L. H. and Thompson, C. B. (1996). Bclx(S) antagonizes the protective effects of Bcl-x(L). Journal of Biological Chemistry, 271, 6306-6312.
17. Cheng, E. H., Levine, B., Boise, L. H., Thompson, C. B. and Hardwick, J. M. (1996). Bax-indepcndent inhibition of apoptosis by Bel-XL. Nature, 379, 554-556.
18. Muchmore, S. W., Sattler, M., Liang, H., Meadows, R. P., Harlan, J. E., Yoon, H. S., Nettesheim, D., Chang, B. S., Thompson, C. B., Wong, S. L., Ng, S. L. and Fesik, S. W. (1996). X-ray and NNÏR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature, 381, 335-341.
19. Park, J. R., Bernstein, I. D. and Hockenberry, D. M. (1995). Primitive human hematopoietic precursors express bclx but not bcl2. Blood, 86, 868-876.
20. Tuscano, J. M., Druey, K. M., Riva, A., Pena, J., Thompson, C. B. and Kehrl, J. H. (1996). Bcl-x rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center. Blood, 88, 1359-1364.
21. Choi, M. S., Holmann, M., Atkins, C. J. and Klaus, G. G. (1996). Expression of bcl-x during mouse B-cell differentiation and following activation by various stimuli. European Journal of Immunology, 26, 676-82.
22. Bakhshi, A., Jensen, J. P., Goldman, P., Wright, J. J., McBride, O. W., Epstein, A. L. and Korsmeyer, S. J. (1985). Cloning the chromosomal breakpoint of 1(14; 18) in human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell, 41, 899-906.
23. Cleary, M. L., Smith, S. D. and Sklar, J. (1986). Cloning and structural analysis of cDNAs for bcl-2 and hybrid bcl-2 immunoglobulin transcript resulting from the t(14;18) translocation. Cell, 47, 19-28.
24. Branet, F., Brousset, P., Krajewski, S., Schlaifer, D., Selves, J., Reed, S. C. and Caron, P. (1996). Expression of the cell death-inducing gene bax in carcinomas developed from the follicular cells of the thyroid gland. Journal of Clinical Endocrinology and Metabolism, 81, 2726-2730.
25. Krajewska, M., Moss, S. F., Krajewski, S., Song, K., Holt, P. R. and Reed, .J. C. (1996). Elevated expression of Bel-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Research, 56, 2422-2427.
26. Naik, P., Karrim, J. and Hanahan, D. (1996). The rise and fall of apoptosis during multi-stage tumorogenesis: down regulation contributes to tumor progresion from angiogenic progenitors. Genes and Development, 10, 2105-2116.
27. Michaud, G. Y., Kamesaki, H. and Cossmän, J. (1996). Expression of bclx in T-cells. Leukemia Research, 20, 683-691.
28. Gauthier, E. R., Piche, L., Lemieux, G. and Lemieux, R. (1996). Role of bcl-X(L) in the control of apoptosis in murine myeloma cells. Cancer Research, 56, 1451-1456.
29. Han, Z., Chatterjee, D., Early, J., Pantazis, P., Hendrickson, E. A. and Wyche, J. H. (I996). Isolation and characterization of an apoptosis-resistant variant of human leukemia HL-60 cells that has switched expression from Bcl-2 to Bcl-xL. Cancer Research, 56, 1621-1628.
30. Schlaifer, D., Krajewski, S., Galoin, G., Rigal-Huguet, F., Laurent, G., Massip, P., Pris, J., Delsol, G., Reed, J. C. and Brousset, P. (1995). Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human deficiency virus infection. American Journal of Pathology, 149, 177-185.
31. Schlaifer, D., March, M., Krajewski, S., Laurent, G., Pris, J., Delsol, G., Reed, J. C. and Brousset, P. (1995). High expression of the Bcl-x gene in Reed Stemberg cells of Hodgkin's disease. Blood, 85, 2671-2674.
32. Xerri, L., Pare, P., Brousset, P., Schlaifer, D., Hassoun, J., Reed, J. C., Krajewski, S. and Birnbaum, D. (1996). Predominant expression of the long isoform of BCL-X (BCL-XL) in human lymphomas. British Journal of Haematology, 92, 900-906.
33. Foreman, K. E., Wrone-Smith, T., Boise, L. H., Thompson, C. G., Polvrerini, P. J., Simonian, P. L., Nunez, G. and Nickoloff, B. J. (1996). Kaposi's sarcoma tumor cells preferentially express Bcl-xL. American Journal of Pathology, 149, 795-803.
34. Krajewski, S., Bodrug, S., Gascoyne, R., Berean, K., Krajewska, M. and Reed, J. C. (1994). Immunohistochemical analysis of mcl-1 and bcl-2 proteins in normal and neoplastic lymph nodes. American Journal of Pathology, 145, 515-525.
35. Armitage, R. J. (1994). Tumor necrosis factor receptor superfamily members and their ligands. Current Biology, 6, 407-113.
36. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y. and Nagata, S. (199I). The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell, 66, 233-243.
37. Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richards, S., Dhein, J., Trauth, B. C., Ponsting, H. and Krammer, P. (1992). Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Journal of Biological Chemistry, 267, 10709-10715.
38. Nagata, S. and Golstein, P. (1995). The Fas death factor. Science, 267, 1449-1456.
39. Schulze-Osthoff, K. (1994). The Fas/APO-1 receptor and its deadly ligand. Trends in Cell Biology, 4, 421-425.
40. Debatin, K. M., Goldman, C. K., Bamford, R., Waldmann, T. A. and Krammer, P. H. (I990). Monoclonal antibody-mediated apoptosis in adult T-cell leukemia. Lancet, 335, 497-500.
41. Debatin, K. M., Goldman, C. K., Waldmann, T. A. and Krammer, P. H. (1993). APO-1 induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood, 81, 2972-2977.
42. Suda, T. and Nagata, S. (1994). Purification and characterization of the Fas ligand that induces apoptosis. Journal of Expérimental Medicine, 179, 873-878.
43. Suda, T., Takahashi, T., Goldstein, P. and Nagata, S. (1993). Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell, 75, 1169-1178.
44. Takahashi, T., Tanaka, M., Inazawa, J., Abe, T., Suda, T. and Nagata, S. (1994). Human FAS ligand : gene structure, chromosomal localization and species specificity. International Immunology, 6, 1567-1574.
45. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A. and Nagata, S. (1992). Lymphoproliferation disorder in mice explained by defects in FAS antigen that mediates apoptosis. Nature, 356, 314-317.
46. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T. and Nagata, S. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the FAS Ligand. Cell, 76, 969-976.
47. Lynch, D. H., Watson, M. L., Alderson, M. R., Baum, P. R., Miller, R. E., Tough, T., Gibson, M., Davis-Smith, T., Smith, C. A., Hunter, K., Bhat, D., Din, W., Goodwin, R. G. and Seidin, M. F. (1994). The mouse FAS-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity, 1, 131-136.
48. Ramsdell, F., Seaman, M. S., Miller, E., Tough, T. W., Alderson, M. R. and Lynch, D. H. (1994). gld/ghl mice are unable to express a functional ligand for FAS. European Journal of Immunology, 24, 928-933.
49. Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middelton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J. and Puck, J. M. (1995). Dominant interfering FAS gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell, 81. 935-946.
50. Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I. A. G., Debatin, K. M., Fischer, A. and de Villartay, J. P. (1995). Mutations in FAS associated with human lymphoproliferative syndrome and autoimmunity. Science, 268, 1347-1349.
51. Xerri, L., Carbuccia, N., Pare, P., Hassoun, J. and Birg, F. (1995). Frequent expression of FAS/APO-1 in Hodgkin's disease and anaplastic large cell lymphomas. Histopathology, 27, 235-241.
52. Xerri, L., Carbuccia, N., Pare, P. and Birg, F. (1995). Search for rearrangements and/or allelic loss of the FAS-APO1 gene in 101 human lymphomas. American Journal of Clinical Pathology, 104, 424-430.
53. Möller, P., Henne, C., Leithäuser, F., Eichelman, A., Schmidt, A., Brüderlein, S., Dhein, J. and Krammer, P. H. (1993). deregulation of the APO-1 antigen with intercellular adhesion molecule-1 (CD54) in tonsillar B-cells and coordinate expression in follicular center B-cells and in follicle center and mediastinal B-cell lymphomas. Blood, 81, 2067-2075.
54. Peng, S. L., Robert, M. A., Mayday, A. C. and Craft, J. (1996). A tumor suppressor function for FAS (CD95) revealed in T-cell deficient mice. Journal of Experimental Medicine, 184, 1149-1154.
55. Westendorf, J. J., Lammert, J. M. and Jelinek, D. F. (1995). Expression and function of FAS (APO-1/CD95) in patient myeloma cells and myeloma cell lines. Blood, 85, 3566-3576.
56. Erhardt, P. and Cooper, G. M. (1996). Activation of the CPP32 apoptotic protease by distinct signaling pathways with differential sensitivity to Bcl-xL. Journal of Biological Chemisliy, Tl\, 17601-17604.
57. Martin, S. J. and Green, D. R. (1995). Protease activation during apoptosis: death by a thousand cuts? Cell, 82, 349-352.
58. Whyte, M. (1996). ICE/CED-3 proteases in apoptosis. Trends in Cell Biology, 6, 245-247.
59. Henkart, P. A. (1996). ICE family proteases: mediators of all apoptotic cell death? Immunity, 4, 195-201.
60. Elis, H. M. and Horvitz, H. R. (1986). Genetic control of programmed cell death in the nematod Caenorhabditis elegans. Cell, 44, 817-829.
61. Yuan, J. and Horvitz, H. R. (1990). Genetic mosaic analysis of ced-3 and ced-4, two genes that control programmed cell death in the nematode C. elegans. Developmental Biology, l38, 33-4\.
62. Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M. and Horvitz, H. R. (1993). The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-lβ-converting enzyme. Cell, 75, 641-652.
63. Cerretti, D. P., Koslosky, C. J., Mosley, B., Nelson, N., Ness, K. V., Greenstreet, T. A., March, C. J., Kronheim, S. R., Druck, T., Cannizaro, L. A., Huebner, K. and Back, R. A. (1995). Molecular cloning of the interleukin-lβ-converting enzyme. Science, 256, 97-100.
64. Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Hownard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J., Elliston, K. O., Ayala, J. M., Casano, F. J., Chin, J., Ding, G. J. F., Egger, L. A., Gaffney, E. P., Limjuco, G., Palyha, O. C., Raju, S. M., Ralando, A. M., Salley, J. P., Yamin, T. T., Lee, T. D., Shivley, J. E., MacCross, M., Mumford, R. A., Schnidt, J. A. and Tocci, M. J. (1992). A novel heterodimeric cysteine protease is required for interleukin-1 p processing in monocytes. Nature, 356, 768-774.
65. Wang, L., Miura, M., Bergeron, L., Zhu, H. and Yuan, J. (1994). Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell, 78, 739-750.
66. Fernandes-Alnemri, T., Litwach, G. and AInemri, E. S. (1994). CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-lβ-converting enzyme. Journal of Biological Chemistry, 269, 30761-30764.
67. Kamens, J., Paskind, M., Hugunin, M., Talanian, R. V., Allen, H., Banach, D., Bump, N., Hackett, M., Johnston, C. G., Li, P., Mankovich, J. A., Terranova, M. and Ghayur, T. (1995). Identification and characterization of ICH-2, a novel member of the interleukin-1 beta-converting enzyme family of cysteine proteases. Journal of Biological Chemistry, 270, 15250-15256.
68. Fernandes-Alnemri, T., Litwack, G. and AInemri, E. S. ( 1995). Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. Cancer Research, 55, 2737-2742.
69. Faucheu, C, Diu, A., Chan, A. \V., Blanchet, A. M., Miossec, C., Hervé, F., Collard-Dutilleul, V., Ou, Y., Aldape, R. A., Lippke, J. A., Rocher, C., Su, M. S. S., Livingston, D. J., Hercend, T. and Lalanne, J. L. (1995). A novel human protcase similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells. EMBO Journal, 14, 1914-1922.
70. Miura, M., Zhu, H., Rotello, R., Hartwieg, E. A. and Yuan, J. (1993). Induction of apoptosis in fibroblasts by IL-lβconverting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell, 75, 653-660.
71. Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E. and Poirier, G. G. (1993). Specific proteolytic cleavage of poly(ADP-ribose) polymera.se: an early marker of chemotherapy-induced apoptosis. Cancer Research, 53, 3976-3985.
72. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G. and Earnshaw, W. C. (1994). Cleavage of poly(ADPribose) polymerase by a proteinase with properties like ICE. Nature, 371, 346-347.
73. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S. and Dixit, V. M. (1995). Yama/CPP32b, a mammalian homolog of CED3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81, 801-809.
74. Gu, Y., Sarnecki, C., Aldape, R. A., Livingston, D. J. and Su, M. S. (1995). Cleavage of poIy(ADP-ribose) polymerase by interleukin-1 beta converting enzyme and its homologs TX and Nedd-2. Journal of Biological Chemistry, 270, 18715-18718.
75. Nicholson, D. W., Ali, A., Thomberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., Munday, N. A., Raju, S. M., Smulson, M. E., Yamin, T. T., Yu, V. L. and Miller, D. K. (1195). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature, 376, 37-43.
76. Enari, M., Talanian, R. V., Wong, W. W. and Nagata, S. (1996). Sequential activation of ICE-Iike and CPP32-like proteases during FAS-mediated apoptosis. Nature, 380, 723-726.
77. Casciola-Rosen, L., Nicholson, D. W., Cong, T., Rowan, K. R., Thornberry, N. A., Miller, D. K. and Rosen, A. (1996). Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. Journal of Experimental Medicine, 183, 1957-1964.
78. Xerri, L., Devilard, E., Ayello, C., Brousset, P., Reed, J. C., Emile, J. F., Hassoun, J., Parmentier, S. and Birg, F. (1997). Cysteine protease CPP32, but not Ichl-L. Is expressed in germinal center B-cells and their neoplastic counterparts. Human Pathology, In press.
79. Sumantran, V. N., Ealovega, M. W., Nunez, G., Clarke, M. F. and Wicha, M. S. (1995). Overexpression of bclx-S sensitizes MCF7 cells to chemotherapy-induced apoptosis. Cancer Research, 55, 2507-2510.
80. Minn, A. J., Rudin, C. M., Boise, L. W. and Thompson, C. B. ( 1995). Expression of bcl-xL can confer a multidrug resistance phenotype. Blood, 86, 1903-1910.
81. Ealovega, M. W., McGinnis, P. K., Sumantran, V. N., Clarke, M. F. and Wicha, M. S. (1996). Bcl-xS gene therapy induces apoptosis of human mammary tumors in nude mice. Cancer Research, 56, 1965-1969.
82. Clarke, M. F., Apel, I. J., Benedict, M. A., Eipers, P. G., Sumantran, V., Gonzalez-Garcia, M., Doedens, M., Fukanaga, M., Davidson, B., Dick, J. E., Minn, A. J., Boise, L. H., Thompson, C. G., Wicha, M. and Nunez, G. (1995). A recombinant bcl-xS adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. Proceedings of the National Academy of Sciences of the United States of America, 92, 11024-11028.